Literature DB >> 30952977

Cancer immunotherapies repurposed for use in autoimmunity.

Dominic A Boardman1,2, Megan K Levings3,4,5.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30952977     DOI： 10.1038/s41551-019-0359-6

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN： 2157-846X            Impact factor:   25.671


× No keyword cloud information.
  7 in total

Review 1.  Treg cell-based therapies: challenges and perspectives.

Authors:  Caroline Raffin; Linda T Vo; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2019-12-06       Impact factor: 53.106

Review 2.  Novel human immunomodulatory T cell receptors and their double-edged potential in autoimmunity, cardiovascular disease and cancer.

Authors:  Pilar Martín; Rafael Blanco-Domínguez; Raquel Sánchez-Díaz
Journal:  Cell Mol Immunol       Date:  2020-11-24       Impact factor: 11.530

Review 3.  Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance.

Authors:  Noémi Anna Nagy; Aram M de Haas; Teunis B H Geijtenbeek; Ronald van Ree; Sander W Tas; Yvette van Kooyk; Esther C de Jong
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

4.  CRISPR activation and interference screens decode stimulation responses in primary human T cells.

Authors:  Ralf Schmidt; Zachary Steinhart; Madeline Layeghi; Jacob W Freimer; Raymund Bueno; Vinh Q Nguyen; Franziska Blaeschke; Chun Jimmie Ye; Alexander Marson
Journal:  Science       Date:  2022-02-04       Impact factor: 63.714

5.  Modeling the Potential of Treg-Based Therapies for Transplant Rejection: Effect of Dose, Timing, and Accumulation Site.

Authors:  Maya M Lapp; Guang Lin; Alexander Komin; Leah Andrews; Mei Knudson; Lauren Mossman; Giorgio Raimondi; Julia C Arciero
Journal:  Transpl Int       Date:  2022-04-11       Impact factor: 3.842

6.  DLL4 and VCAM1 enhance the emergence of T cell-competent hematopoietic progenitors from human pluripotent stem cells.

Authors:  Yale S Michaels; John M Edgar; Matthew C Major; Elizabeth L Castle; Carla Zimmerman; Ting Yin; Andrew Hagner; Charles Lau; Han Hsuan Hsu; M Iliana Ibañez-Rios; Lauren J Durland; David J H F Knapp; Peter W Zandstra
Journal:  Sci Adv       Date:  2022-08-24       Impact factor: 14.957

Review 7.  From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment.

Authors:  Stephan Klöß; Susann Dehmel; Armin Braun; Michael J Parnham; Ulrike Köhl; Susanne Schiffmann
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.